ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP10-25 Omada for Prevention
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဖ့ၤဘြူၤအါရံၤ 12, 2025
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 3391 - 3400 လၢ 3669 အစၢတဖၣ်အကျါ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Ohtuvayre™ - Medicaid - Effective Date 02/01/2025
Prior Authorization, Quantity Limit
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဖ့ၤဘြူၤအါရံၤ 01, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P6-25 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဖ့ၤဘြူၤအါရံၤ 03, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P7-25 Prime Therapeutics Management (UM) Program: Medical Drug Updates
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဖ့ၤဘြူၤအါရံၤ 03, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P8-25 Update to Reimbursement Policy: Commercial General Coding 074 Cellular and Gene Therapy Product
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဖ့ၤဘြူၤအါရံၤ 03, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
2025 February Bulletins
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဖ့ၤဘြူၤအါရံၤ 03, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Medical and Behavioral Health Policy Activity Effective April 7, 2025
ကျိၣ်စ့တၢ်ဂ့ၢ်တၢ်ကျိၤ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Commercial Reimbursement Policy Intraoperative Neurophysiological Monitoring (IONM)
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Duvyzat™ - Commercial
Prior Authorization, Quantity Limit
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 01, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Duvyzat™ - Medicaid
Prior Authorization, Quantity Limit
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 01, 2025